NovAccess Global Inc. (OTCMKTS:XSNX – Get Free Report) was the target of a large decline in short interest in the month of April. As of April 15th, there was short interest totalling 400 shares, a decline of 99.4% from the March 31st total of 65,900 shares. Based on an average trading volume of 1,568,900 shares, the days-to-cover ratio is presently 0.0 days.
NovAccess Global Stock Performance
OTCMKTS:XSNX opened at $0.01 on Friday. The business’s fifty day moving average is $0.01 and its 200 day moving average is $0.03. The firm has a market cap of $178,484.70, a price-to-earnings ratio of -0.05 and a beta of 1.51. NovAccess Global has a 52-week low of $0.01 and a 52-week high of $0.22.
NovAccess Global (OTCMKTS:XSNX – Get Free Report) last posted its earnings results on Tuesday, February 27th. The company reported $0.01 earnings per share for the quarter.
NovAccess Global Company Profile
NovAccess Global Inc, a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.
Featured Stories
- Five stocks we like better than NovAccess Global
- What Is WallStreetBets and What Stocks Are They Targeting?
- Hasbro’s Management Made All the Right Calls This Quarter
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for NovAccess Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovAccess Global and related companies with MarketBeat.com's FREE daily email newsletter.
